These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2703391)

  • 1. Toxicity of RSU-1069 for KHT cells treated in vivo or in vitro: evidence for a diffusible toxic product.
    Hill RP; Gulyas S; Whitmore GF
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1111-4. PubMed ID: 2703391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chemosensitizing and cytotoxic effects of RSU 1164 and RSU 1165 in a murine tumor model.
    Siemann DW
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1115-8. PubMed ID: 2703392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of the in vivo and in vitro cytotoxicity of the drug RSU-1069.
    Hill RP; Gulyas S; Whitmore GF
    Br J Cancer; 1986 Jun; 53(6):743-51. PubMed ID: 3755053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual-function 2-nitroimidazoles as hypoxic cell radiosensitizers and bioreductive cytotoxins: in vivo evaluation in KHT murine sarcomas.
    Cole S; Stratford IJ; Adams GE; Fielden EM; Jenkins TC
    Radiat Res; 1990 Oct; 124(1 Suppl):S38-43. PubMed ID: 2236508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual function nitroimidazoles less toxic than RSU 1069: selection of candidate drugs for clinical trial (RB 6145 and/or PD 130908.
    Cole S; Stratford IJ; Fielden EM; Adams GE; Leopold W; Elliott W; Suto M; Sebolt-Leopold J
    Int J Radiat Oncol Biol Phys; 1992; 22(3):545-8. PubMed ID: 1735694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oxygenation, pH and hyperthermia on RSU-1069 in vitro and in vivo with radiation in the FSaIIC murine fibrosarcoma.
    Teicher BA; Herman TS; Holden SA; Rudolph MB
    Cancer Lett; 1991 Aug; 59(2):109-17. PubMed ID: 1884367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The radiosensitizing and toxic effects of RSU-1069 on hypoxic cells in a murine tumor.
    Chaplin DJ; Durand RE; Stratford IJ; Jenkins TC
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1091-5. PubMed ID: 3755714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral (po) dosing with RSU 1069 or RB 6145 maintains their potency as hypoxic cell radiosensitizers and cytotoxins but reduces systemic toxicity compared with parenteral (ip) administration in mice.
    Cole S; Stratford IJ; Bowler J; Nolan J; Wright EG; Lorimore SA; Adams GE
    Int J Radiat Oncol Biol Phys; 1991 Jul; 21(2):387-95. PubMed ID: 2061115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of radiation resistant hypoxic cell subpopulations in KHT sarcomas. (II). Cell sorting.
    Siemann DW; Keng PC
    Br J Cancer; 1988 Sep; 58(3):296-300. PubMed ID: 3179180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic contribution to the improved therapeutic selectivity of a novel bromoethylamino prodrug (RB 6145) of the mixed-function hypoxic cell sensitizer/cytotoxin alpha-(1-aziridinomethyl)-2-nitro-1H-imidazole-1-ethanol (RSU 1069).
    Binger M; Workman P
    Cancer Chemother Pharmacol; 1991; 29(1):37-47. PubMed ID: 1742848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor sensitizing effect by misonidazole in a clinically relevant radiation dose range.
    Grdina DJ; Thames HD; Milas L
    Int J Radiat Oncol Biol Phys; 1984 Mar; 10(3):379-83. PubMed ID: 6706731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of melphalan activity in the KHT sarcoma by the radiosensitizer RSU 1069.
    Siemann DW; Maddison K; Wolf K
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1657-60. PubMed ID: 6548212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the toxicity of RSU-1069.
    Whitmore GF; Gulyas S
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1219-22. PubMed ID: 3755716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analogues of RSU-1069: radiosensitization and toxicity in vitro and in vivo.
    Ahmed I; Jenkins TC; Walling JM; Stratford IJ; Sheldon PW; Adams GE; Fielden EM
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1079-81. PubMed ID: 3755711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing of hypoxic cell radiosensitizers in vivo.
    Rauth AM; Chin J; Marchow L; Paciga J
    Br J Cancer Suppl; 1978 Jun; 3():202-5. PubMed ID: 277228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytocidal effects of misonidazole, Ro 03-8799, and RSU-1164 on euoxic and hypoxic BP-8 murine sarcoma cells at normal and elevated temperatures.
    Hofer KG; Lakkis M; Hofer MG
    Cancer; 1989 Apr; 63(8):1501-8. PubMed ID: 2924258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of alkylating chemotherapy by dual function nitrofurans in multi-cell spheroids and solid tumors.
    Siemann DW; Sutherland RM
    Radiother Oncol; 1992 Aug; 24(4):239-45. PubMed ID: 1410579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation of the radiosensitizing efficiency of RSU-1069 with pre-irradiation contact times: a rapid mix study.
    Austen KR; Jenner TJ; O'Neill P; Fielden EM
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Aug; 52(2):281-8. PubMed ID: 3497125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of environmental conditions (pH, oxygenation, and temperature) on misonidazole cytotoxicity and radiosensitization in vitro and in vivo in FSaIIC fibrosarcoma.
    Holden SA; Teicher BA; Herman TS
    Int J Radiat Oncol Biol Phys; 1991 May; 20(5):1031-8. PubMed ID: 2022503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxicity of RSU 1069 in spheroids and murine tumors.
    Olive PL; Durand RE; Chaplin DJ
    Int J Radiat Oncol Biol Phys; 1987 Sep; 13(9):1361-6. PubMed ID: 3624045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.